FDA Postpones Routine Domestic Inspections To Protect Agency Staff

FDA has postponed all routine domestic facility inspections in order to protect the health and well-being of agency staff and to address industry’s concern over visitors, FDA announced Wednesday (March 18), coming as the Trump administration advises against unnecessary travel due to the nationwide spread of COVID-19. The agency will still proceed with inspections it deems “mission-critical,” as well as respond to all public health emergencies involving FDA-regulated products. Only routine surveillance facility inspections have been postponed at this time...